Evidence map›Paper›PMID 29522907›Full record

ArticleNitric oxide : biology and chemistry2018

Nitric oxide reduces oxidative stress in cancer cells by forming dinitrosyliron complexes.

Sumit Sahni, Jason R Hickok, Douglas D Thomas

Abstract read
In one paragraph

Article in Nitric oxide : biology and chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Thionitrite (SNOAngewandte Chemie (International ed. in English) · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Sumit SahniMolecular Pharmacology and Pathology Program, Department of Pathology, University of Sydney, Australia.
Jason R HickokDepartment of Medicinal Chemistry & Pharmacognosy, University of Illinois at Chicago, Chicago, IL 60612, USA.
Douglas D ThomasDepartment of Medicinal Chemistry & Pharmacognosy, University of Illinois at Chicago, Chicago, IL 60612, USA. Electronic address: ddthomas@uic.edu.
University of Illinois Chicago · USUniversity of Sydney · AU

Funding

Structure and function of chloride channels and transportersR01GM085232 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI ACCARDI, ALESSIO · 2009 to 2013
$1.7M
The role of dinitrosyliron complexes in cancer etiologyR01GM094175 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI THOMAS, DOUGLAS D. · 2011 to 2014
$978k
NIGMS NIH HHS R01 GM085232NIGMS NIH HHS R01 GM094175
6 · The paper itself

Abstract

The chelatable iron pool (CIP) is a small but chemically significant fraction of total cellular iron. While this dynamic population of iron is limited, it is redox active and capable of generating reactive oxygen species (ROS) that can lead to oxidative stress which is associated with various pathologies. Nitric oxide (•NO), is a free radical signalling molecule that regulates numerous physiological and pathological conditions. We have previously shown that macrophages exposed to endogenously generated or exogenously administered nitric oxide (•NO) results in its interaction with CIP to form dinitrosyliron complexes with thiol containing ligands (DNICs). In this study we assessed the consequences of DNIC formation in cancer cells as •NO is known to be associated with numerous malignancies. Incubation of cancer cells with •NO led to a time and dose dependent increase in formation of DNICs. The formation of DNICs results in the sequestration of the CIP which is a major source of iron for redox reactions and reactive oxygen species (ROS) generation. Therefore, we set out to test the antioxidant effect of •NO by measuring the ability of DNICs to protect cells against oxidative stress. We observed that cancer cells treated with •NO were partially protected against H

Indexed as

Breast NeoplasmsCell SurvivalColonic NeoplasmsFemaleHumansHydrogen PeroxideIronNitric OxideNitrogen OxidesOxidation-ReductionOxidative StressTumor Cells, Cultureddinitrosyl iron complexHydrogen PeroxideIronNitric OxideNitrogen OxidesCancerChelatable ironDinitrosyliron complexesNitric oxideOxidative stress

Identifiers

PMID29522907
PMCPMC5916741
OpenAlexW2789692986

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.